Literature DB >> 29110251

Inhibition of two gastric cancer cell lines induced by fucoxanthin involves downregulation of Mcl-1 and STAT3.

Rui-Xue Yu1, Rui-Tao Yu2,3, Zhong Liu4.   

Abstract

Fucoxanthin is a natural carotenoid that had never been previously demonstrated to have anti-tumor effect on human gastric adenocarcinoma SGC-7901 or BGC-823 cells. Here it was found to inhibit proliferation and induce apoptosis through JAK/STAT signal pathway in these cells; the mechanism by which this occurred was investigated. We find that fucoxanthin significantly increased the number of apoptotic cells by propidium iodide (PI) dye staining and flow cytometry. Fucoxanthin (50 or 75 μM) induced SGC-7901 cells cycle arrest at S phase, while BGC-823 cells arrest at G2/M phase. RT-PCR and western blot analysis revealed that the expressions of Mcl-1, STAT3 and p-STAT3 were obviously decreased by fucoxanthin in a dose-dependent manner. Synthetic siRNA targeting Mcl-1 was transfected into cells which had no effect on expressions of STAT3. After pretreatment with AG490 (50 μM) which led to blocking of the JAK/STAT signal pathway, the reductive expressions of Mcl-1, STAT3 and p-STAT3 caused by fucoxanthin were inhibited. This is the first analysis of effects on SGC-7901 and BGC-823 cells by fucoxanthin. Fucoxanthin can induce cell-cycle arrest and apoptosis in these cells. These effects involved downregulation of Mcl-1, STAT3 and p-STAT3. This work is significant for better understanding of mechanisms leading to human gastric adenocarcinoma formation and informing exploitation of anti-tumor marine drug, and for providing Mcl-1 and STAT3 as potential therapeutic targets for gastric adenocarcinoma.

Entities:  

Keywords:  Fucoxanthin; Gastric adenocarcinoma; Mcl-1; STAT3

Mesh:

Substances:

Year:  2017        PMID: 29110251     DOI: 10.1007/s13577-017-0188-4

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  17 in total

1.  Effects of fucoxanthin on proliferation and apoptosis in human gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway.

Authors:  Rui-Xue Yu; Xia-Min Hu; Shi-Qiang Xu; Zheng-Ju Jiang; Wen Yang
Journal:  Eur J Pharmacol       Date:  2010-12-24       Impact factor: 4.432

Review 2.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Authors:  Hua Yu; Heehyoung Lee; Andreas Herrmann; Ralf Buettner; Richard Jove
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

3.  Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin.

Authors:  Jing Zhou; Choon-Nam Ong; Gang-Min Hur; Han-Ming Shen
Journal:  Biochem Pharmacol       Date:  2009-12-21       Impact factor: 5.858

4.  Roles of activated Src and Stat3 signaling in melanoma tumor cell growth.

Authors:  Guilian Niu; Tammy Bowman; Mei Huang; Steve Shivers; Douglas Reintgen; Adil Daud; Alfred Chang; Alan Kraker; Richard Jove; Hua Yu
Journal:  Oncogene       Date:  2002-10-10       Impact factor: 9.867

5.  Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells.

Authors:  Masashi Hosokawa; Masahiro Kudo; Hayato Maeda; Hiroyuki Kohno; Takuji Tanaka; Kazuo Miyashita
Journal:  Biochim Biophys Acta       Date:  2004-11-18

6.  Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D.

Authors:  Swadesh K Das; Takashi Hashimoto; Kazuki Kanazawa
Journal:  Biochim Biophys Acta       Date:  2008-01-12

7.  Transcriptional and translational control of Mcl-1 during apoptosis.

Authors:  Daniel Iglesias-Serret; Maria Piqué; Joan Gil; Gabriel Pons; José M López
Journal:  Arch Biochem Biophys       Date:  2003-09-15       Impact factor: 4.013

Review 8.  Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance.

Authors:  Alfonso Quintás-Cardama; Srdan Verstovsek
Journal:  Clin Cancer Res       Date:  2013-02-13       Impact factor: 12.531

Review 9.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

Review 10.  Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment.

Authors:  Luc J Martin
Journal:  Mar Drugs       Date:  2015-07-31       Impact factor: 5.118

View more
  10 in total

Review 1.  Insight into the Progress on Natural Dyes: Sources, Structural Features, Health Effects, Challenges, and Potential.

Authors:  Nannan Li; Qirou Wang; Jingna Zhou; Shuqin Li; Junyu Liu; Haixia Chen
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

Review 2.  A Systematic Review on Marine Algae-Derived Fucoxanthin: An Update of Pharmacological Insights.

Authors:  Md Mohibbullah; Md Nazmul Haque; Abdullah Al Mamun Sohag; Md Tahmeed Hossain; Md Sarwar Zahan; Md Jamal Uddin; Md Abdul Hannan; Il Soo Moon; Jae-Suk Choi
Journal:  Mar Drugs       Date:  2022-04-22       Impact factor: 6.085

3.  Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer.

Authors:  Qiuyuan Wen; Yuting Zhan; Hongmei Zheng; Hongjing Zang; Jiadi Luo; Yuting Zhang; Weiyuan Wang; Juan Feng; Junmi Lu; Lingjiao Chen; Songqing Fan
Journal:  Diagn Pathol       Date:  2019-10-10       Impact factor: 2.644

4.  Effects of Syringic Acid on Apoptosis, Inflammation, and AKT/mTOR Signaling Pathway in Gastric Cancer Cells.

Authors:  Jinjin Pei; Periyannan Velu; Mohsen Zareian; Zili Feng; Annamalai Vijayalakshmi
Journal:  Front Nutr       Date:  2021-12-14

Review 5.  Anti-Inflammatory and Anticancer Effects of Microalgal Carotenoids.

Authors:  Javier Ávila-Román; Sara García-Gil; Azahara Rodríguez-Luna; Virginia Motilva; Elena Talero
Journal:  Mar Drugs       Date:  2021-09-23       Impact factor: 5.118

Review 6.  Brown Algae as Functional Food Source of Fucoxanthin: A Review.

Authors:  Nur Akmal Solehah Din; 'Ain Sajda Mohd Alayudin; Noor-Soffalina Sofian-Seng; Hafeedza Abdul Rahman; Noorul Syuhada Mohd Razali; Seng Joe Lim; Wan Aida Wan Mustapha
Journal:  Foods       Date:  2022-07-27

Review 7.  Fucoxanthin: A Promising Phytochemical on Diverse Pharmacological Targets.

Authors:  Mumtaza Mumu; Ayan Das; Talha Bin Emran; Saikat Mitra; Fahadul Islam; Arpita Roy; Md Mobarak Karim; Rajib Das; Moon Nyeo Park; Deepak Chandran; Rohit Sharma; Mayeen Uddin Khandaker; Abubakr M Idris; Bonglee Kim
Journal:  Front Pharmacol       Date:  2022-08-02       Impact factor: 5.988

Review 8.  STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Sima Orouei; Vahideh Zarrin; Ebrahim Rahmani Moghadam; Amirhossein Zabolian; Shima Mohammadi; Kiavash Hushmandi; Yashar Gharehaghajlou; Pooyan Makvandi; Masoud Najafi; Reza Mohammadinejad
Journal:  Biology (Basel)       Date:  2020-06-12

9.  Fucoxanthin administration delays occurrence of tumors in xenograft mice by colonospheres, with an anti-tumor predictor of glycine.

Authors:  Masaru Terasaki; Naoya Matsumoto; Ryuichi Hashimoto; Tetsuya Endo; Hayato Maeda; Junichi Hamada; Kazumi Osada; Kazuo Miyashita; Michihiro Mutoh
Journal:  J Clin Biochem Nutr       Date:  2018-07-25       Impact factor: 3.114

10.  Dietary Fucoxanthin Induces Anoikis in Colorectal Adenocarcinoma by Suppressing Integrin Signaling in a Murine Colorectal Cancer Model.

Authors:  Masaru Terasaki; Mimori Ikuta; Hiroyuki Kojima; Takuji Tanaka; Hayato Maeda; Kazuo Miyashita; Michihiro Mutoh
Journal:  J Clin Med       Date:  2019-12-29       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.